Baird analysts anticipate Insulet's earnings to grow faster ...

Moomoo AI Dec 26, 2023 13:34

Baird analysts anticipate Insulet's earnings to grow faster than their annual sales of approx. 20%. DexCom's margins predicted to expand with sales growth over 20% annually before GLP-1s impact. Boston Scientific considered a top-level medtech enterprise by Baird's Rescott.

3 Medical-Device Stocks Could Click in 2024 -- Barrons.com

Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more

Translate

Report

68K Views

Comment

Moomoo AI

Moomoo AI Official Account

Your AI assistant for discovering investment opportunities.

3277Followers

0Following

8054Visitors